Carolyn D. Britten, MD
Carolyn D. Britten, MD, is an Associate Professor in the Division of Hematology/Oncology, Department of Medicine at MUSC, and holds the Charles Westfield Coker Disinguished Endowed Chair in Gastrointestinal Oncology supported by the South Carolina SmartState Program. She trained in medical oncology at the University of British Columbia in Vancouver, Canada, and completed a two-year clinical research fellowship in Phase I clinical trials at the Institute for Drug Development in San Antonio, Texas. As a faculty member at the University of California, Los Angeles (UCLA) for 11 years, she developed the solid tumor Phase I clinical trials program. She joined MUSC/HCC in July 2012 with the charge of further developing the Phase I clinical trials effort at the Hollings Cancer Center and enhancing the growth of the Developmental Cancer Therapeutics Program.